Fred Graff Net Worth & Insider Trades
Fred Graff - Chief Commercial Officer, Recro Pharma, Inc
What is Fred Graff's Net Worth?
The current estimated net worth of Recro Pharma, Inc's Chief Commercial Officer, Fred Graff, is estimated to be about $240.77K . Fred Graff owns about 8,000 units of Recro Pharma, Inc common stock. In the last 2 years at Recro Pharma, Inc, Fred Graff has sold an estimated value of $16.15K worth.
What is Fred Graff's Past Insider Trading?
Fred Graff's largest purchase order was 8,000 units , worth over $67.71K on June 2, 2016. In total, Fred Graff has made about 6 transactions over 2 years of their time at Recro Pharma, Inc. Fred Graff usually trades in January, with the busiest year in 2016, 2018 and 2017.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Fred Graff
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Fred Graff's' Mailing Address?
- Mailing address is C/o Recro Pharma, Inc. 490 Lapp Road Malvern PA 19355 PA
Recro Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. David Enloe, Jr. | 2020 | $10,577 | - | $660,001 | $400,544 | - | $1,678 | $1,072,800 |
| Ryan D. Lake | 2020 | $198,985 | $48,000 | $1,058,040 | $744,327 | $107,640 | $24,673 | $2,181,665 |
| Ryan D. Lake | 2019 | $319,777 | $69,440 | $623,276 | $334,200 | $138,880 | $44,038 | $1,529,611 |
| Gerri Henwood | 2020 | $308,654 | $111,240 | - | - | - | $21,166 | $441,060 |
| Gerri Henwood | 2019 | $553,846 | - | $2,608,537 | $1,062,199 | $360,000 | $38,402 | $4,622,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm
What are Recro Pharma, Inc's Past Insider Trades?
Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer, Geraldine Henwood, Director, and Scp Vitalife Partners Ii Lp .
Recro Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||